A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China

Objective: This research aims to analyze the application regularity of Chinese patent medicine during the COVID-19 epidemic by collecting the names of the top three Chinese patent medicines used by 24 hospitals in 14 provinces of China in four time periods (January 20–22, February 16–18, March 01–03...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Nan, Shi, Nannan, Li, Siyu, Liu, Guoxiu, Han, Yonglong, Liu, Li, Zhang, Xin, Kong, Xiangwen, Zhang, Bihua, Yuan, Wenpeng, Liu, Yi, Deng, Deqiang, Zheng, Minxia, Zhang, Ying, Li, Lihua, Wang, Xiaoping, Wu, Jiankun, Lin, Xiaolan, Nian, Hua, Wu, Xiaohong, Wang, Hua, Liu, Fang, Wang, Hongli, Wang, Hongshun, Liu, Ying, Zeng, Weixin, Yang, Manqin, Wang, Yanping, Zhai, Huaqiang, Wang, Yongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990099/
https://www.ncbi.nlm.nih.gov/pubmed/33776751
http://dx.doi.org/10.3389/fphar.2020.574562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990099/
https://www.ncbi.nlm.nih.gov/pubmed/33776751
http://dx.doi.org/10.3389/fphar.2020.574562

Ejemplares similares